The costs come from things like the extraordinarily high cost of getting FDA approvals reducing competition between pharma companies, doctors choosing unnecessary tests for liability reasons and patients preferring them when someone else is paying for them and things of that nature.

You missed the biggest one: massively overcompensated specialty physicians. We can expect price controls to reduce that. And since there is currently a massive surplus of qualified applicants to medical schools, we shouldn't expect shortages either.